rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2002-9-4
|
pubmed:abstractText |
Prior research has documented the under-representation in clinical trials of older patients with cancer. In part of a larger study to test the magnitude of these barriers to entering eligible older patients with carcinoma of the breast into clinical trials (Cancer and Leukemia Group B [CALGB] trial 9670), barriers to accruing eligible older patients to clinical trials were obtained from the physician's perspective.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0008-543X
|
pubmed:author |
pubmed-author:BartlettNancyN,
pubmed-author:Cancer and Leukemia Group B,
pubmed-author:CohenHarvey JayHJ,
pubmed-author:CrawfordJeffreyJ,
pubmed-author:FlemingGiniG,
pubmed-author:GrazianoStephenS,
pubmed-author:KemenyMargaretM,
pubmed-author:KornblithAlice BAB,
pubmed-author:MussHymanH,
pubmed-author:PetersonBercedis LBL,
pubmed-author:WheelerJudithJ
|
pubmed:copyrightInfo |
Copyright 2002 American Cancer Society.
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
95
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
989-96
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12209681-Adult,
pubmed-meshheading:12209681-Aged,
pubmed-meshheading:12209681-Aging,
pubmed-meshheading:12209681-Breast Neoplasms,
pubmed-meshheading:12209681-Clinical Trials as Topic,
pubmed-meshheading:12209681-Comorbidity,
pubmed-meshheading:12209681-Eligibility Determination,
pubmed-meshheading:12209681-Female,
pubmed-meshheading:12209681-Humans,
pubmed-meshheading:12209681-Middle Aged,
pubmed-meshheading:12209681-Patient Compliance,
pubmed-meshheading:12209681-Patient Selection,
pubmed-meshheading:12209681-Perception,
pubmed-meshheading:12209681-Risk Factors
|
pubmed:year |
2002
|
pubmed:articleTitle |
Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials.
|
pubmed:affiliation |
Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. alice_kornblith@dfci.harvard.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|